Sir Marc Feldmann

Senior Research Fellow, Professor of Cellular Immunology, Director of Kennedy Institute of Rheumatology
Oxford's Kennedy Institute of Rheumatology

Sir Marc Feldmann is the head of Oxford’s Kennedy Institute of Rheumatology.

Sir Marc was one of the recipients of the 2014 Canada Gairdner International Awards, often seen as a predictor for the Nobel Prize for Medicine.

He received his award alongside research colleague Sir Ravinder Nath Maini, a Visiting Professor at the Institute, “for the discovery of anti-TNF therapy for the treatment of rheumatoid arthritis and other inflammatory diseases”.

Recent publications

Fully reduced HMGB1 accelerates the regeneration of multiple tissues by transitioning stem cells to GAlert. Journal article; Lee G. et al, (2018), Proc Natl Acad Sci U S A, 115

Developments in therapy with monoclonal antibodies and related proteins. Journal article; Shepard HM. et al, (2017), Clin Med (Lond), 17, 220 – 232


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.